126380-84-5

Upstream product

• 120-92-3 cyclopentanone 
• 2389-45-9 Boc-Lys(Z)-OH 
• 126333-57-1 N-(N^α-tert-butoxycarbonyl-N^ε-carbobenzoxy-L-lysyl)-N-cyclopentyl glycine ethyl ester 
• 84126-69-2 N-cyclopentyl glycine ethyl ester hydrochloride 

Downstream Products

• 94739-04-5 N-(N^ε-carbobenzoxy-L-lysyl)-N-cyclopentyl glycine 
• 126380-81-2 N-α-(1-carbethoxy-3-phenylpropyl)-N^ε-benzyloxycarbonyl-L-lysyl>-N-cyclopentyl glycine 
• 126333-45-7 N-α-(1-carbethoxy-3-cyclohexylpropyl)-N^ε-benzyloxycarbonyl-L-lysyl>-N-cyclopentyl glycine 
• 94739-05-6 N-α-(1-carboxy-3-phenylpropyl)-N^ε-benzyloxycarbonyl-L-lysyl>-N-cyclopentyl glycine 
• 126333-41-3 N-α-(1-carboxy-3-cyclohexylpropyl)-N^ε-benzyloxycarbonyl-L-lysyl>-N-cyclopentyl glycine 
• 120285-32-7 N-α-(1-carboxy-3-cyclohexylpropyl)-L-lysyl>-N-cyclopentyl glycine 

Relevant academic research and scientific papers

Synthesis and angiotensin converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives

The synthesis and biological activity of novel L-lysyl-N-substituted glycine derivatives which exhibit in vitro and in vivo angiotensin converting enzyme (ACE) inhibition, are described. Particularly, N-[N(α)-(1-carboxy-3-phenylpropyl)-L-lysyl]-N-(4-pheny